Prodia provides wearable and disposable biochip platforms that continuously monitor blood protein levels linked to chronic diseases. Their ProBand wearable performs low‑cost, single‑use assays and sends real‑time alerts of acute protein spikes to physicians, while the ProBox/Nexus system offers rapid, plug‑and‑play protein quantification for research labs, both backed by AI‑driven analytics and secure cloud data management.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with chronic conditions such as heart failure often experience acute protein level spikes (e.g., ProBNP) that signal worsening disease, but current monitoring relies on infrequent clinic visits or bulky equipment, leading to delayed interventions.
Solution
Prodia offers wearable and disposable biochip platforms that continuously track blood protein concentrations associated with chronic diseases. The ProBand wearable incorporates a low‑cost, single‑use assay that measures target proteins in real time and automatically transmits elevated readings to a physician’s dashboard, enabling timely clinical response. For research settings, the ProBox/Nexus system provides a plug‑and‑play, piezoelectric detection platform that delivers quantitative protein results within 30–60 minutes using disposable chips and AI‑assisted analytics. Both solutions integrate cloud data storage and real‑time alerts, reducing the need for manual laboratory workflows and supporting proactive disease management.
Target Audience
Primary customers are clinicians managing chronic disease patients (e.g., cardiologists, heart failure specialists) and academic or commercial research laboratories that require fast, cost‑effective protein quantification.
Features
- Disposable biochip assay for frequent, low‑cost protein testing
- Wearable ProBand device with continuous monitoring and automatic physician notifications during acute elevations
- Nexus/ProBox platform that detects any target protein via piezoelectric sensing on a single-use chip
- AI‑driven software that captures, analyzes, and visualizes assay data in real time
- Cloud‑based data management with secure storage and sharing capabilities
- Rapid turnaround (30–60 min) compared to traditional ELISA or Western blot methods
- Multi‑analyte capability allowing simultaneous testing of several biomarkers